Fecal microbiota transplantation induces hepatitis B virus e-antigen (HBeAg) clearance in patients with positive HBeAg after long-term antiviral therapy

Hepatology. 2017 May;65(5):1765-1768. doi: 10.1002/hep.29008. Epub 2017 Mar 16.

Authors

Yan-Dan Ren¹, Zhen-Shi Ye¹, Liu-Zhu Yang¹, Li-Xin Jin¹, Wen-Jun Wei¹, Yong-Yue Deng², Xiao-Xiao Chen², Chuan-Xing Xiao¹, Xiao-Fang Yu³, Hong-Zhi Xu¹, Li-Zhu Xu¹, Yun-Na Tang¹, Fei Zhou¹, Xue-Lian Wang², Mei-Ya Chen¹, Li-Gang Chen¹, Mei-Zhu Hong⁴, Jian-Lin Ren¹, Jin-Shui Pan¹

Affiliations

¹ Zhongshan Hospital Department of Gastroenterology, Xiamen University, Xiamen, China.
² Zhongshan Hospital Department of Infectious Diseases, Xiamen University, Xiamen, China.
³ Hepatology Unit and Department of Infectious Diseases, Xiamen Hospital of Traditional Chinese Medicine, Xiamen, China.
⁴ Zhongshan Hospital Department of Traditional Chinese Medicine, Xiamen University, Xiamen, China.

PMID: 28027582
DOI: 10.1002/hep.29008

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Adult
Antiviral Agents / therapeutic use*
Case-Control Studies
Fecal Microbiota Transplantation*
Female
Gastrointestinal Microbiome / immunology
Hepatitis B e Antigens / analysis*
Hepatitis B, Chronic / immunology
Hepatitis B, Chronic / therapy*
Hepatitis B, Chronic / virology*
Humans
Male

Substances

Antiviral Agents
Hepatitis B e Antigens